Facebook Twitter YouTube  
Contact Us
Research Spotlight
Home > Clinical Trials & Research > Research Spotlight
Print

Clinical Trials & Research

Research Spotlight

Montefiore is the University Hospital for Albert Einstein College of Medicine. This unique partnership brings together expertise across disciplines and yields an extensive portfolio of biomedical research, with an emphasis on translating basic science in the lab to pioneering treatments and therapies. Montefiore physicians are discovering novel solutions that advance the future of healthcare and treatments:

Improving Access to Cancer Care for Minority and Underserved Communities

While cancer mortality rates are declining, minority and underserved populations have yet to show improvement. Through an NIH grant, Montefiore-Einstein researchers Joseph Sparano, MD, Mark Einstein, MD, MS and Bruce Rapkin, PhD are working to change this.

As one of 12 sites to participate in the NCI Community Oncology Research Program (NCORP), Montefiore will use the $3.4 million grant to reduce healthcare disparities in cancer care. The program will be conducted at Montefiore Einstein Center for Cancer Care, our premier cancer center that provides patient-centered care for prevention, diagnosis and treatment of cancer. The NCORP research will be directed by three investigators: Dr. Sparano will lead efforts in cancer therapeutics; Dr. Einstein will oversee cancer prevention; and Dr. Rapkin will focus on cancer control and delivery.

“Albert Einstein Cancer Center has played a key leadership role in therapeutic cancer trials and has received funding from NCI for nearly four decades to support its role as a main member institution of the Eastern Cooperative Oncology Group,” says Dr. Sparano. “The NCORP funding will support expanding activities in the areas of cancer prevention, cancer control and cancer care delivery research.”

In addition to leading cancer clinical research at Montefiore, Dr. Sparano has focused on enhancing the access of minority populations to cancer clinical trials as an essential component of contemporary cancer care. “Cancer mortality rates are declining rapidly as a result of improved treatment, screening and prevention, but improvements have lagged in minority populations,” adds Dr. Sparano. “Clinical trials have provided a foundation for much of this improvement. The NCORP mechanism will allow us to integrate new approaches that may address this disparity.”

Joseph Sparano, MD, is Professor of Medicine and of Obstetrics and Gynecology and Women's Health, and Associate Director of Clinical Research, Einstein; and Vice Chairman of Medical Oncology, Center for Cancer Care.

Mark Einstein, MD, MS, is Professor and Director of Oncology Research in the Department of Obstetrics and Gynecology and Women's Health, Einstein; and Vice Chair of Research for Obstetrics and Gynecology and Women's Health, Center for Cancer Care.

Bruce Rapkin, PhD, is Professor of Epidemiology and Population Health at Einstein and Center for Cancer Care.

 

?